Ticker: XLV CUSIP: 81369Y209 Class: SBI HEALTHCARE
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 1,135,000 | $175,698 | — | — |
| Q3 2025 | 1,135,000 | $157,958 | — | — |
| Q2 2025 | 1,000,000 | $134,790 | — | — |
| Q1 2025 | 1,460,000 | $213,175 | — | — |
| Q4 2024 | 1,460,000 | $200,852 | — | — |
| Q3 2024 | 2,180,000 | $335,764 | — | — |
| Q2 2024 | 1,120,000 | $163,240 | — | — |
| Q1 2024 | 920,000 | $135,912 | — | — |
| Q4 2023 | 920,000 | $125,470 | — | — |
| Q3 2023 | 920,000 | $118,441 | — | — |
| Q2 2023 | 420,000 | $55,747 | — | — |
| Q1 2023 | 420,000 | $54,373 | — | — |
| Q4 2022 | 770,000 | $104,605 | — | — |
| Q2 2022 | 1,050,000 | $134,652 | — | — |
| Q1 2022 | 1,100,000 | $150,689 | — | — |
| Q4 2021 | 1,550,000 | $218,380 | — | — |
| Q3 2021 | 2,110,000 | $268,603 | — | — |
| Q2 2021 | 2,610,000 | $328,730 | — | — |
| Q1 2021 | 2,250,000 | $262,665 | — | — |
| Q4 2020 | 2,276,700 | $258,269 | — | — |
| Q3 2020 | 10,287 | $1,085 | — | — |
| Q2 2020 | 4,962 | $497 | — | — |
| Q4 2019 | 2,520,200 | $256,708 | — | — |